Alternatives to Pyxis Diagnostics

Leveraging the adaptive immune system to diagnose and treat disease.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

AI-powered spatial biology platform for precision medicine and drug development.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.

Microbiome drug discovery company developing customized phage therapies for chronic diseases.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Harnessing genetic data for digital insights in rare and germline disorders.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

N-Power Medicine is a healthcare technology company transforming oncology drug development and community cancer patient care.

Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.

Early-stage clinical company developing smart targeted radioligands for precision oncology.

Making targeted DNA sequencing as common, fast, and affordable as a blood test.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

Transforming healthcare by turning scientific fiction into scientific facts.